IB
REGN icon

Intrust Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Intrust Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$481K Buy
623
+187
+43% +$143K 0.04% 265
2025
Q4 		$337K Buy
436
+19
+5% +$12.9K 0.03% 313
2025
Q3 		$234K Sell
417
-272
-39% -$154K 0.02% 373
2025
Q2 		$362K Sell
689
-644
-48% -$359K 0.03% 311
2025
Q1 		$845K Hold
1,333
– – 0.08% 169
2024
Q4 		$950K Sell
1,333
-282
-17% -$237K 0.1% 154
2024
Q3 		$1.7M Buy
1,615
+3
+0.2% +$3.34K 0.17% 104
2024
Q2 		$1.69M Sell
1,612
-34
-2% -$33K 0.18% 102
2024
Q1 		$1.58M Sell
1,646
-27
-2% -$25.7K 0.17% 114
2023
Q4 		$1.47M Buy
1,673
+53
+3% +$43.6K 0.17% 114
2023
Q3 		$1.33M Sell
1,620
-28
-2% -$22K 0.17% 107
2023
Q2 		$1.18M Buy
1,648
+8
+0.5% +$6.17K 0.14% 128
2023
Q1 		$1.35M Buy
1,640
+108
+7% +$81.5K 0.17% 111
2022
Q4 		$1.11M Buy
1,532
+107
+8% +$79K 0.15% 128
2022
Q3 		$982K Buy
1,425
+172
+14% +$108K 0.15% 126
2022
Q2 		$741K Buy
1,253
+14
+1% +$9.1K 0.11% 169
2022
Q1 		$865K Buy
1,239
+223
+22% +$141K 0.11% 170
2021
Q4 		$641K Buy
1,016
+20
+2% +$12.3K 0.08% 208
2021
Q3 		$603K Buy
996
+110
+12% +$68.3K 0.08% 208
2021
Q2 		$495K Buy
886
+147
+20% +$74.5K 0.07% 231
2021
Q1 		$350K Buy
739
+303
+69% +$148K 0.05% 278
2020
Q4 		$211K Buy
436
+65
+18% +$35.1K 0.03% 343
2020
Q3 		$208K Buy
+371
New +$225K 0.04% 320

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Intrust Bank's REGN Position: Q1 2026 in Review

Intrust Bank increased its Regeneron Pharmaceuticals (REGN) stake by 43% in Q1 2026, buying an estimated $143K and bringing the position to 623 shares worth $481K. The position accounts for 0.04% of the portfolio, ranked #265.

Intrust Bank first reported a position in REGN in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.7M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Intrust Bank held 623 shares of Regeneron Pharmaceuticals worth $481K as of Q1 2026.
  • Intrust Bank bought 187 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $143K.
  • Regeneron Pharmaceuticals made up 0.04% of Intrust Bank's portfolio in Q1 2026, its #265 holding.
  • Intrust Bank first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Intrust Bank's Regeneron Pharmaceuticals position peaked at $1.7M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.